.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cancer-associated fibroblasts (CAFs) represent a critical component of the tumor microenvironment. These cells significantly drive cancer development, recurrence, and metastasis. Recent research highlights the importance of targeting cancer-associated fibroblasts to disrupt their protumorigenic functions. By understanding the signaling pathways that govern CAF behavior, scientists can develop more effective therapeutic strategies.
Several intracellular pathways regulate the activation and survival of CAFs. The PI3K/AKT/mTOR and JAK/STAT pathways are primary drivers of fibroblast progression. Additionally, the TGF-β and NF-κB signaling cascades play essential roles in maintaining the CAF phenotype. Inhibiting these pathways can suppress the supportive role CAFs play in tumor growth. Furthermore, targeting the ferroptosis pathway offers a unique mechanism to specifically eliminate these cells. This selective killing could potentially enhance the efficacy of traditional chemotherapy.
Small molecule drugs are increasingly favored in drug development due to their distinct chemical properties. These compounds feature well-dispersed spatial structures that facilitate excellent druggability. Moreover, they often exhibit promising pharmacokinetic profiles. Consequently, small molecules can effectively reach and modulate signaling targets within complex tumor tissues. Researchers are currently evaluating various inhibitors of the TGF-β and JAK/STAT pathways in clinical settings.
New therapeutic strategies focus on combining CAF-targeted agents with standard oncology treatments. For instance, activators of apoptosis and autophagy can further weaken the stromal support of the tumor. Therefore, these compounds underscore the clinical significance of the tumor stroma. Ongoing studies suggest that modulating the fibroblast environment could prevent cancer recurrence. This shift toward stroma-targeted therapy represents a major advancement in precision medicine.
CAFs are a specialized type of cell within the tumor microenvironment that promote cancer growth and resistance to therapy.
Targeting the ferroptosis signaling pathway can specifically induce cell death in CAFs, thereby reducing their tumor-promoting effects.
Small molecule drugs possess favorable spatial structures and pharmacokinetic profiles, making them highly effective at reaching intracellular signaling targets.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wan Y et al. Emerging agents that target signaling pathways in cancer fibroblast cells (Review). Int J Oncol. 2026 Jul 69: 87. doi: 10.3892/ijo.2026.5900. PMID: 42246174.
Wu S et al. Identification of Small-Molecule Inhibitors Targeting Different Signaling Pathways in Cancer-Associated Fibroblast Reprogramming under Tumor-Stroma Interaction. J Invest Dermatol. 2025 Jan;145(1):65-76.e13. doi: 10.1016/j.jid.2024.04.026.
Agrawal S et al. FDA approvals in 2024: New options for patients across cancer types and therapeutic classes. Nat Rev Clin Oncol. 2025 (in press).
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of small molecule compounds targeting signaling pathways in cancer-associated fibroblasts, offering new strategies for inhibiting tumor progression...
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
